Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Here's Why GSK (GSK) is a Strong Value Stock
Here's Why GSK (GSK) is a Strong Value Stock

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The popular research

Is ARKO (ARKO) a Great Value Stock Right Now?
Is ARKO (ARKO) a Great Value Stock Right Now?

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always

Is Biodesix (BDSX) Stock Outpacing Its Medical Peers This Year?
Is Biodesix (BDSX) Stock Outpacing Its Medical Peers This Year?

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Biodesix, Inc. (BDSX) is a stock that can certainly grab the

Is SkyWest (SKYW) a Great Value Stock Right Now?
Is SkyWest (SKYW) a Great Value Stock Right Now?

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop

Why BP (BP) is a Top Value Stock for the Long-Term
Why BP (BP) is a Top Value Stock for the Long-Term

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The research service

Is CarMax (KMX) Stock Undervalued Right Now?
Is CarMax (KMX) Stock Undervalued Right Now?

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With

Why Centene (CNC) is a Top Value Stock for the Long-Term
Why Centene (CNC) is a Top Value Stock for the Long-Term

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service

Are Investors Undervaluing Centerra Gold (CGAU) Right Now?
Are Investors Undervaluing Centerra Gold (CGAU) Right Now?

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With

Should Value Investors Buy Wolverine World Wide (WWW) Stock?
Should Value Investors Buy Wolverine World Wide (WWW) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the

Has Atlanta Braves Holdings, Inc. (BATRK) Outpaced Other Consumer Discretionary Stocks This Year?
Has Atlanta Braves Holdings, Inc. (BATRK) Outpaced Other Consumer Discretionary Stocks This Year?

For those looking to find strong Consumer Discretionary stocks, it is prudent to search for companies in the group that are outperforming their peers. Atlanta Braves Holdings (BATRK) is a stock that

Is Adecoagro (AGRO) Outperforming Other Consumer Staples Stocks This Year?
Is Adecoagro (AGRO) Outperforming Other Consumer Staples Stocks This Year?

The Consumer Staples group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Adecoagro (AGRO) been one of those stocks this

Cardinal Health (CAH) is a Top-Ranked Value Stock: Should You Buy?
Cardinal Health (CAH) is a Top-Ranked Value Stock: Should You Buy?

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Why Cummins (CMI) is a Top Value Stock for the Long-Term
Why Cummins (CMI) is a Top Value Stock for the Long-Term

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

Featuring daily updates

Is FrancoNevada (FNV) Stock Outpacing Its Basic Materials Peers This Year?
Is FrancoNevada (FNV) Stock Outpacing Its Basic Materials Peers This Year?

For those looking to find strong Basic Materials stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Franco-Nevada (FNV) one of those stocks right now

Theravance Biopharma (TBPH) Q4 Earnings and Revenues Lag Estimates
Theravance Biopharma (TBPH) Q4 Earnings and Revenues Lag Estimates

Theravance Biopharma (TBPH) came out with quarterly earnings of $0.06 per share, missing the Zacks Consensus Estimate of $0.44 per share. This compares to a loss of $0.05 per share a year ago. These

Is GIS' Portfolio Reshaping Strategy Key to Long-Term Growth?
Is GIS' Portfolio Reshaping Strategy Key to Long-Term Growth?

General Mills, Inc. GIS continues to actively reshape the business portfolio as part of its long-term growth strategy. In line with this effort, the company recently announced a move to streamline

Zacks Industry Outlook Highlights Equity Residential and Equity LifeStyle Properties
Zacks Industry Outlook Highlights Equity Residential and Equity LifeStyle Properties

For Immediate Release

Chicago, IL – March 19, 2026 – Today, Zacks Equity Research discusses Equity Residential EQR and Equity LifeStyle Properties ELS.

Industry: Residential REIT

Link: https://www.z

Implied Volatility Surging for Bar Harbor Bankshares Stock Options
Implied Volatility Surging for Bar Harbor Bankshares Stock Options

Investors in Bar Harbor Bankshares BHB need to pay close attention to the stock based on moves in the options market lately. That is because the April 17, 2026 $15.00 Call had some of the highest

Buy 3 Stocks That Announced Dividend Hikes Amid Geopolitical Tensions
Buy 3 Stocks That Announced Dividend Hikes Amid Geopolitical Tensions

Wall Street has been hit by turbulence. Rising inflation has once again raised concerns about an economic slowdown, as the Federal Reserve left interest rates unchanged on Wednesday. Also

Bank of America's Digitization Initiatives Unlocking Revenue Growth
Bank of America's Digitization Initiatives Unlocking Revenue Growth

Bank of America’s BAC push to embed artificial intelligence (AI) and digital tools deeper into its franchise is emerging as a meaningful revenue-growth lever, not just an efficiency story. Last

After Plunging 12.0% in 4 Weeks, Here's Why the Trend Might Reverse for ResMed (RMD)
After Plunging 12.0% in 4 Weeks, Here's Why the Trend Might Reverse for ResMed (RMD)

ResMed (RMD) has been on a downward spiral lately with significant selling pressure. After declining 12% over the past four weeks, the stock looks well positioned for a trend reversal as it is now

Down 14% in 4 Weeks, Here's Why Toyota Motor (TM) Looks Ripe for a Turnaround
Down 14% in 4 Weeks, Here's Why Toyota Motor (TM) Looks Ripe for a Turnaround

A downtrend has been apparent in Toyota Motor Corporation (TM) lately with too much selling pressure. The stock has declined 14% over the past four weeks. However, given the fact that it is now in

Down 13.9% in 4 Weeks, Here's Why You Should You Buy the Dip in Hancock Whitney (HWC)
Down 13.9% in 4 Weeks, Here's Why You Should You Buy the Dip in Hancock Whitney (HWC)

Hancock Whitney (HWC) has been on a downward spiral lately with significant selling pressure. After declining 13.9% over the past four weeks, the stock looks well positioned for a trend reversal as

After Plunging 22.0% in 4 Weeks, Here's Why the Trend Might Reverse for Sprout Social (SPT)
After Plunging 22.0% in 4 Weeks, Here's Why the Trend Might Reverse for Sprout Social (SPT)

Sprout Social (SPT) has been on a downward spiral lately with significant selling pressure. After declining 22% over the past four weeks, the stock looks well positioned for a trend reversal as it

Down 15.5% in 4 Weeks, Here's Why Octave Specialty (OSG) Looks Ripe for a Turnaround
Down 15.5% in 4 Weeks, Here's Why Octave Specialty (OSG) Looks Ripe for a Turnaround

Octave Specialty Group (OSG) has been on a downward spiral lately with significant selling pressure. After declining 15.5% over the past four weeks, the stock looks well positioned for a trend